In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model

Biochemical Pharmacology

Volumn 70, Issue 8, 2005, Pages 1222-1230

  Törmäkangas, Liisa ^a   Vuorela, Pia ^b   Saario, Elise ^a   Leinonen, Maija ^a   Saikku, Pekka ^c   Vuorela, Heikki ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Chlamydia pneumoniae; Lung infection; Luteolin; Mouse; Octyl gallate; Quercetin

Indexed keywords

BACTERIUM ANTIBODY; FLAVONOID; GALLIC ACID DERIVATIVE; GALLIC ACID OCTYL ESTER; LUTEOLIN; QUERCETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; HISTOLOGY; INFLAMMATION; INOCULATION; LUNG PARENCHYMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; BASE SEQUENCE; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DISEASE MODELS, ANIMAL; DNA PRIMERS; DNA, VIRAL; FEMALE; GALLIC ACID; LUNG; LUTEOLIN; MICE; MICE, INBRED C57BL; NITRATES; ORGAN CULTURE TECHNIQUES; QUERCETIN;

EID: 24944489242     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.07.012     Document Type: Article

References (54)

1. G.R. Beecher Overview of dietary flavonoids: nomenclature, occurrence and intake J Nutr 133 2003 3248S 3254S
2. M.G.L. Hertog, P.C.H. Hollman, and M.B. Katan Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands J Agric Food Chem 40 1992 2379 2383
3. J. Reed Cranberry flavonoids, atherosclerosis and cardiovascular health Crit Rev Food Sci Nutr 42 2002 301 316
4. M. Aviram, L. Dornfeld, M. Kaplan, R. Coleman, D. Gaitini, and S. Nitecki Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans Drugs Exp Clin Res 28 2002 49 62
5. W. Ren, Z. Qiao, H. Wang, L. Zhu, and L. Zhang Flavonoids: promising anticancer agents Med Res Rev 23 2003 519 534
6. P. Kumar, S. Sharma, M. Khanna, and H.G. Raj Effect of quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection Int J Exp Pathol 84 2003 127 133
7. O.I. Aruoma, A. Murcia, J. Butler, and B. Halliwell Evaluation of the antioxidant and prooxidant actions of gallic acid and its derivatives J Agric Food Chem 41 1993 1880 1885
8. H.T. Huynh, and R.W. Teel Effects of plant-derived phenols on rat liver cytochrome P450 2B1 activity Anticancer Res 22 2002 1699 1703
9. C.R. Pace-Asciak, S. Hahn, E.P. Diamandis, G. Soleas, and D.M. Goldberg The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease Clin Chim Acta 235 1995 207 219
10. T.N. Kaul, E. Middleton Jr., and P.L. Ogra Antiviral effect of flavonoids on human viruses J Med Virol 15 1985 71 79
11. M.M. Cowan Plant products as antimicrobial agents Clin Microbiol Rev 12 1999 564 582
12. I. Kubo, K. Fujita, K. Nihei, and A. Nihei Antibacterial activity of alkyl gallates against Bacillus subtilis J Agric Food Chem 52 2004 1072 1076
13. J.P. Rauha, S. Remes, M. Heinonen, A. Hopia, M. Kähkönen, and T. Kujala Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds Int J Food Microbiol 56 2000 3 12
14. H.X. Xu, and S.F. Lee Activity of plant flavonoids against antibiotic-resistant bacteria Phytother Res 15 2001 39 43
15. A. Xagorari, A. Papapetropoulos, A. Mauromatis, M. Economou, T. Fotsis, and C. Roussos Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages J Pharmacol Exp Ther 296 2001 181 187
16. S.Y. Cho, S.J. Park, M.J. Kwon, T.S. Jeong, S.H. Bok, and W.Y. Choi Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage Mol Cell Biochem 243 2003 153 160
17. A. Kotanidou, A. Xagorari, E. Bagli, P. Kitsanta, T. Fotsis, and A. Papapetropoulos Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice Am J Respir Crit Care Med 165 2002 818 823
18. T. Murase, N. Kume, T. Hase, Y. Shibuya, Y. Nishizawa, and I. Tokimitsu Gallates inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of leukocyte adhesion molecules in vascular endothelial cells Arterioscler Thromb Vasc Biol 19 1999 1412 1420
19. S.C. Shen, W.R. Lee, H.Y. Lin, H.C. Huang, C.H. Ko, and L.L. Yang In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production Eur J Pharmacol 446 2002 187 194
20. M. Leinonen, and P. Saikku Evidence for infectious agents in cardiovascular disease and atherosclerosis Lancet Infect Dis 2 2002 11 17
21. D.L. Hahn Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann Allergy Asthma Immunol 83 1999 271 288
22. M. Smieja, J. Mahony, A. Petrich, J. Boman, and M. Chernesky Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review BMC Infect Dis 2 2002 21
23. T.C. Moazed, C.C. Kuo, J.T. Grayston, and L.A. Campbell Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse J Infect Dis 177 1998 1322 1325
24. S.S. Kaukoranta-Tolvanen, A.L. Laurila, P. Saikku, M. Leinonen, L. Liesirova, and K. Laitinen Experimental infection of Chlamydia pneumoniae in mice Microb Pathog 15 1993 293 302
25. J.M. Vuola, V. Puurula, M. Anttila, P.H. Maäelä, and N. Rautonen Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge Infect Immun 68 2000 960 964
26. E. Blessing, T.M. Lin, L.A. Campbell, M.E. Rosenfeld, D. Lloyd, and C. Kuo Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice Infect Immun 68 2000 4765 4768
27. T.C. Moazed, L.A. Campbell, M.E. Rosenfeld, J.T. Grayston, and C.C. Kuo Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice J Infect Dis 180 1999 238 241
28. J. Zhu, A.A. Quyyumi, J.E. Norman, G. Csako, M.A. Waclawiw, and G.M. Shearer Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels Am J Cardiol 85 2000 140 146
29. P. Vuorela, M. Leinonen, P. Saikku, P. Tammela, J.P. Rauha, and T. Wennberg Natural products in the process of finding new drug candidates Curr Med Chem 11 2004 1375 1389
30. L. Törmäkangas, H. Alakärppä, D. Bem David, M. Leinonen, and P. Saikku Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice Antimicrob Agents Chemother 48 2004 3655 3661
31. L. Erkkilä, K. Laitinen, A. Laurila, P. Saikku, and M. Leinonen Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue Vaccine 20 2002 2318 2324
32. C.A. Gaydos, T.C. Quinn, and J.J. Eiden Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene J Clin Microbiol 30 1992 796 800
33. U. Reischl, N. Lehn, U. Simnacher, R. Marre, and A. Essig Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR Eur J Clin Microbiol Infect Dis 22 2003 54 57
34. M. Phillipson, J. Henriksnas, M. Holstad, S. Sandler, and L. Holm Inducible nitric oxide synthase is involved in acid-induced gastric hyperemia in rats and mice Am J Physiol Gastrointest Liver Physiol 285 2003 G154 G162
35. U. Laufs, K. Gertz, U. Dirnagl, M. Bohm, G. Nickenig, and M. Endres Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice Brain Res 942 2002 23 30
36. D.A. Simpson, S. Feeney, C. Boyle, and A.W. Stitt Retinal VEGF mRNA measured by SYBR green I fluorescence: a versatile approach to quantitative PCR Mol Vis 6 2000 178 183
37. R. Dechend, M. Maass, J. Gieffers, R. Dietz, C. Scheidereit, and A. Leutz Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis Circulation 100 1999 1369 1373
38. J.T. Baer, T.V. Du Laney, P.B. Wyrick, A.S. McCain, T.A. Fischer, and E.P. Merricks Nuclear factor-kappaB activation in endothelium by Chlamydia pneumoniae without active infection J Infect Dis 188 2003 1094 1097
39. A. Kol, T. Bourcier, A.H. Lichtman, and P. Libby Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages J Clin Invest 103 1999 571 577
40. P. Tammela, L. Laitinen, A. Galkin, T. Wennberg, R. Heczko, and H. Vuorela Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles Arch Biochem Biophys 425 2004 193 199
41. T. Walle, T.S. Vincent, and U.K. Walle Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells Biochem Pharmacol 65 2003 1603 1610
42. A. Plaper, M. Golob, I. Hafner, M. Oblak, T. Solmajer, and R. Jerala Characterization of quercetin binding site on DNA gyrase Biochem Biophys Res Commun 306 2003 530 536
43. A.C. Cheng, T.C. Huang, C.S. Lai, and M.H. Pan Induction of apoptosis by luteolin through cleavage of Bcl-2 family in human leukemia HL-60 cells Eur J Pharmacol 509 2005 1 10
44. S.F. Fischer, T. Harlander, J. Vier, and G. Hacker Protection against CD95-induced apoptosis by chlamydial infection at a mitochondrial step Infect Immun 72 2004 1107 1115
45. A. Veckenstedt, J. Guttner, and I. Beladi Failure of high doses of potentially antiviral agents to prevent death in virus-infected mice Acta Virol 29 1985 216 224
46. Alvesalo J, Vuorela HJ, Tammela P, Leinonen M, Saikku P, Vuorela PM. Inhibition potential of dietary phenolic compounds against Chlamydia pneumoniae infection in cell cultures, submitted for publication.
47. C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am J Clin Nutr 79 2004 727 747
48. J.P. Spencer, G.G. Kuhnle, R.J. Williams, and C. Rice-Evans Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites Biochem J 372 2003 173 181
49. E.U. Graefe, J. Wittig, S. Mueller, A.K. Riethling, B. Uehleke, and B. Drewelow Pharmacokinetics and bioavailability of quercetin glycosides in humans J Clin Pharmacol 41 2001 492 499
50. K. Shimoi, N. Saka, R. Nozawa, M. Sato, I. Amano, and T. Nakayama Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation Drug Metab Dispos 29 2001 1521 1524
51. C. Manach, C. Morand, V. Crespy, C. Demigne, O. Texier, and F. Regerat Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties FEBS Lett 426 1998 331 336
52. X. Vitrac, A. Desmouliere, B. Brouillaud, S. Krisa, G. Deffieux, and N. Barthe Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration Life Sci 72 2003 2219 2233
53. D.D. Schramm, H.E. Collins, and J.B. German Flavonoid transport by mammalian endothelial cells J Nutr Biochem 10 1999 193 197
54. T. Yamazaki, M. Inoue, N. Sasaki, T. Hagiwara, T. Kishimoto, and S. Shiga In vitro inhibitory effects of tea polyphenols on the proliferation of Chlamydia trachomatis and Chlamydia pneumoniae Jpn J Infect Dis 56 2003 143 145